Eline Meyers

Mrs. Eline Meyers

Ghent University, Ghent, Belgium
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2021 in Microbiology Spectrum
Verified
Journal Article
Open access
EMEline Meyers
Eline Meyers
SHStefan Heytens
Stefan Heytens
AFAsangwing Formukong
Asangwing Formukong
HVHanne Vercruysse
Hanne Vercruysse
ASAn De Sutter
An De Sutter
PCPiet Cools
Piet Cools
Since the implementation of newly developed SARS-CoV-2 vaccines in the general population, serological tests are of increasing importance. Because DBS samples can be obtained with a finger prick and can be shipped and stored at room temperature, they are optimal for use in large-scale SARS-CoV-2 serosurveillance or postauthorization vaccination studies, even in an elderly study population.

28 November 2022 in European Journal of General Practice
Verified
Journal Article
Open access
EMEline Meyers
Eline Meyers
LRLiselore De Rop
Liselore De Rop
EDEllen Deschepper
Ellen Deschepper
EDEls Duysburgh
Els Duysburgh
TBTine De Burghgraeve
Tine De Burghgraeve
SHStefan Heytens
Stefan Heytens
Nursing home residents (NHR) and staff have been disproportionally affected by the COVID-19 pandemic and were therefore prioritised in the COVID-19 vaccination strategy. However, frail older adults...

19 August 2022 in Journal of Clinical Virology
Verified
Journal Article
Closed access
EMEline Meyers
Eline Meyers
ACAnja Coen
Anja Coen
ASAn De Sutter
An De Sutter
EPElizaveta Padalko
Elizaveta Padalko
SCSteven Callens
Steven Callens
PCPiet Cools
Piet Cools

12 April 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Marina DigregorioMarina Digregorio
Marina Digregorio
PNPauline Van Ngoc
Pauline Van Ngoc
SDSimon Delogne
Simon Delogne
EMEline Meyers
Eline Meyers
EDEllen Deschepper
Ellen Deschepper
BSBeatrice Scholtes
Beatrice Scholtes
In Belgium, nursing home staff (NHS) and residents were prioritised for COVID-19 vaccination. However, vaccine hesitancy may have impacted vaccination rates. In this study, a random stratified sample of NHS (N = 1142), vaccinated and unvaccinated, completed an online questionnaire on COVID-19 vaccine hesitancy (between 31 July and 15 November 2021). NHS who hesitated or refused the vaccine were asked for the main reason for their hesitation/refusal. Those who hesitated, but eventually accepted vaccination, were asked why they changed their minds. Overall, 29.5% of all respondents hesitated before accepting vaccination, were still hesitating, or refused vaccination. Principal reasons were fear of unknown future effects (55.1% of vaccinated participants that hesitated and 19.5% who refused), fear of side-effects (12.7% of vaccinated participants that hesitated and 12.2% who refused), and mistrust in vaccination (10.5% of vaccinated participants that hesitated and 12.2% who refused). For vaccinated participants who hesitated initially, protecting the vulnerable was the main reason they changed their minds. Given this degree of fear and proposals to mandate vaccination among healthcare workers, communicating with NHS on the safety and efficacy of the vaccine should be prioritised.

4 March 2025 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
NBNatalja Van Biesen
Natalja Van Biesen
PCPiet Cools
Piet Cools
EMEline Meyers
Eline Meyers
Background/Objectives: DNA extraction from dried blood spot (DBS) samples is often applied in neonatal screening programs. Although various methods to extract DNA from DBSs have been described, the optimal approach remains unclear. Therefore, this study aimed to compare and optimize extraction methods to establish a reliable and efficient protocol for human DNA extraction from DBSs. Methods: We conducted a back-to-back comparison of five different DNA extraction methods on 20 DBS samples: three column-based kits (QIAamp DNA mini kit, High Pure PCR Template Preparation kit, DNeasy Blood & Tissue kit) and two in-house boiling methods (one using TE buffer, one using Chelex-100 resin). DNA recovery was measured with DeNovix DS-11 and ACTB qPCR. Further optimization of elution volumes and starting material was performed on the best-performing methods (sample size = 5). Additionally, T-cell receptor excision circle (TREC) DNA was assessed by qPCR as an application. Results: The Chelex boiling method yielded significantly (p < 0.0001) higher ACTB DNA concentrations compared to the other methods. Column-based methods showed low DNA recovery, except for Roche, which showed significantly (p < 0.0001) higher DNA concentrations than the other column-based methods, as measured by DeNovix DS-11. Decreasing elution volumes (150 vs. 100 vs. 50 µL) increased ACTB DNA concentrations significantly, while increasing starting material (two vs. one 6 mm spot) did not. Conclusions: We identified an easy and cost-effective optimized DNA extraction method using Chelex from DBSs, with an elution volume of 50 µL and 1 × 6 mm DBS punch, which is particularly advantageous for research in low-resource settings and large populations, such as neonatal screening programs.

26 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
EMEline Meyers
Eline Meyers
EDEllen Deschepper
Ellen Deschepper
EDEls Duysburgh
Els Duysburgh
LRLiselore De Rop
Liselore De Rop
TBTine De Burghgraeve
Tine De Burghgraeve
SHStefan Heytens
Stefan Heytens
In the SCOPE study, we monitored SARS-CoV-2 antibodies in a national sample of residents and staff from Belgian nursing homes. Here, we report the seroprevalence among infected and infection-naive residents and staff after the primary COVID-19 vaccination campaign. Among 1554 vaccinated nursing home residents and 1082 vaccinated staff from 69 nursing homes in Belgium, we assessed the proportion having SARS-CoV-2 antibodies approximately two (April 2021), four (June 2021), and six months (August 2021) after a two-dose regimen of the BNT162b2 vaccine. We measured the seroprevalence using SARS-CoV-2 antibody rapid tests and collected socio-demographic and COVID-19 medical data using an online questionnaire. Two months after vaccination (baseline), we found a seroprevalence of 91% (95% CI: 89–93) among vaccinated residents and 99% (95% CI: 98–99) among vaccinated staff. Six months after vaccination, the seroprevalence significantly decreased to 68% (95% CI: 64–72) among residents and to 89% (95% CI; 86–91) among staff (p < 0.001). The seroprevalence was more likely to decrease among infection-naive residents, older residents, or residents with a high care dependency level. These findings emphasize the need for close monitoring of nursing home residents, as a substantial part of this population fails to mount a persistent antibody response after BNT162b2 vaccination.